Company: GCTS
Filing Date: 2025-05-13
Form Type: S-3/A
Source: 0001104659-25-047808
Chunk: 8

Company: GCT Semiconductor Holding, Inc.
Filing Date: 2025-05-13
Form: S-3/A
Chunk 8
---
 prospectus also relates
to the issuance by us of up to 26,273,653 shares of our common stock underlying warrants.

In addition, the Selling
Securityholders may use this registration statement to offer and sell up to an aggregate of 36,261,987 shares of Common Stock, 6,580,000
Private Placement Warrants and 148,320 Anapass Warrants from time to time through any means described in the section titled “Plan of Distribution”.We will not receive any proceeds from the sale by such Selling Securityholders of the securities offered
by them described in this prospectus. This prospectus also relates to the issuance by us of the shares of Common Stock issuable upon
the exercise of any Warrants. We will not receive any proceeds from the sale of shares of Common Stock underlying the Warrants pursuant
to this prospectus, except with respect to amounts received by us upon the exercise of the Warrants for cash. The exercise of the Warrants,
and any proceeds we may receive from their exercise, are highly dependent on the price of any of our shares of Common Stock and the spread
between the exercise price of the Warrants and the price of our Common Stock at the time of exercise. If the market price of our Common
Stock is less than the exercise price of a holder’s Warrants, it is unlikely that holders will exercise their Warrants. There can
be no assurance that any of our Warrants will be in the money prior to their expiration.

A prospectus supplement may
also add, update or change information included in this prospectus. Any statement contained in this prospectus will be deemed to be modified
or superseded for purposes of this prospectus to the extent that a statement contained in such prospectus supplement modifies or supersedes
such statement. Any statement so modified will be deemed to constitute a part of this prospectus only as so modified, and any statement
so superseded will be deemed not to constitute a part of this prospectus. You should rely only on the information contained in this prospectus,
any applicable prospectus supplement or any related free writing prospectus. See section titled “Where You Can Find More Information.”

Neither we nor the Selling
Securityholders have authorized anyone to provide any information or to make any representations other than those contained in this prospectus,
any accompanying prospectus supplement or any free writing prospectus we have prepared. We and the Selling Securityholders take no responsibility
for, and can provide no assurance as to the reliability of